When injections and pills are counter-indicated, transdermal and transmucosal delivery systems may get drugs into the body with great efficacy and beneficial results.
Market Analysis and Insights: Global Transdermal and Transmucosal Drug Delivery Market
The global Transdermal and Transmucosal Drug Delivery market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Transdermal and Transmucosal Drug Delivery market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Transdermal and Transmucosal Drug Delivery, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Transdermal and Transmucosal Drug Delivery, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Transdermal and Transmucosal Drug Delivery revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Transdermal and Transmucosal Drug Delivery market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Transdermal and Transmucosal Drug Delivery revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
3M
Antares Pharma
Aveva Drug Delivery Systems
Corium International
DURECT
Pantec Biosolutions
Tapemark
Tesa Labtec
Segment by Type
Transdermal Drug Delivery
Transmucosal Drug Delivery
Segment by Application
Clinics
Hospitals
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Transdermal and Transmucosal Drug Delivery in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Transdermal and Transmucosal Drug Delivery companies鈥� competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Transdermal and Transmucosal Drug Delivery revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Transdermal and Transmucosal Drug Delivery Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Transdermal Drug Delivery
1.2.3 Transmucosal Drug Delivery
1.3 Market by Application
1.3.1 Global Transdermal and Transmucosal Drug Delivery Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Clinics
1.3.3 Hospitals
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Transdermal and Transmucosal Drug Delivery Market Perspective (2019-2030)
2.2 Global Transdermal and Transmucosal Drug Delivery Growth Trends by Region
2.2.1 Transdermal and Transmucosal Drug Delivery Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Transdermal and Transmucosal Drug Delivery Historic Market Size by Region (2019-2024)
2.2.3 Transdermal and Transmucosal Drug Delivery Forecasted Market Size by Region (2025-2030)
2.3 Transdermal and Transmucosal Drug Delivery Market Dynamics
2.3.1 Transdermal and Transmucosal Drug Delivery Industry Trends
2.3.2 Transdermal and Transmucosal Drug Delivery Market Drivers
2.3.3 Transdermal and Transmucosal Drug Delivery Market Challenges
2.3.4 Transdermal and Transmucosal Drug Delivery Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Transdermal and Transmucosal Drug Delivery by Players
3.1.1 Global Transdermal and Transmucosal Drug Delivery Revenue by Players (2019-2024)
3.1.2 Global Transdermal and Transmucosal Drug Delivery Revenue Market Share by Players (2019-2024)
3.2 Global Transdermal and Transmucosal Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Transdermal and Transmucosal Drug Delivery, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Transdermal and Transmucosal Drug Delivery Market Concentration Ratio
3.4.1 Global Transdermal and Transmucosal Drug Delivery Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Transdermal and Transmucosal Drug Delivery Revenue in 2023
3.5 Global Key Players of Transdermal and Transmucosal Drug Delivery Head office and Area Served
3.6 Global Key Players of Transdermal and Transmucosal Drug Delivery, Product and Application
3.7 Global Key Players of Transdermal and Transmucosal Drug Delivery, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Transdermal and Transmucosal Drug Delivery Breakdown Data by Type
4.1 Global Transdermal and Transmucosal Drug Delivery Historic Market Size by Type (2019-2024)
4.2 Global Transdermal and Transmucosal Drug Delivery Forecasted Market Size by Type (2025-2030)
5 Transdermal and Transmucosal Drug Delivery Breakdown Data by Application
5.1 Global Transdermal and Transmucosal Drug Delivery Historic Market Size by Application (2019-2024)
5.2 Global Transdermal and Transmucosal Drug Delivery Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Transdermal and Transmucosal Drug Delivery Market Size (2019-2030)
6.2 North America Transdermal and Transmucosal Drug Delivery Market Size by Type
6.2.1 North America Transdermal and Transmucosal Drug Delivery Market Size by Type (2019-2024)
6.2.2 North America Transdermal and Transmucosal Drug Delivery Market Size by Type (2025-2030)
6.2.3 North America Transdermal and Transmucosal Drug Delivery Market Share by Type (2019-2030)
6.3 North America Transdermal and Transmucosal Drug Delivery Market Size by Application
6.3.1 North America Transdermal and Transmucosal Drug Delivery Market Size by Application (2019-2024)
6.3.2 North America Transdermal and Transmucosal Drug Delivery Market Size by Application (2025-2030)
6.3.3 North America Transdermal and Transmucosal Drug Delivery Market Share by Application (2019-2030)
6.4 North America Transdermal and Transmucosal Drug Delivery Market Size by Country
6.4.1 North America Transdermal and Transmucosal Drug Delivery Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Transdermal and Transmucosal Drug Delivery Market Size by Country (2019-2024)
6.4.3 North America Transdermal and Transmucosal Drug Delivery Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Transdermal and Transmucosal Drug Delivery Market Size (2019-2030)
7.2 Europe Transdermal and Transmucosal Drug Delivery Market Size by Type
7.2.1 Europe Transdermal and Transmucosal Drug Delivery Market Size by Type (2019-2024)
7.2.2 Europe Transdermal and Transmucosal Drug Delivery Market Size by Type (2025-2030)
7.2.3 Europe Transdermal and Transmucosal Drug Delivery Market Share by Type (2019-2030)
7.3 Europe Transdermal and Transmucosal Drug Delivery Market Size by Application
7.3.1 Europe Transdermal and Transmucosal Drug Delivery Market Size by Application (2019-2024)
7.3.2 Europe Transdermal and Transmucosal Drug Delivery Market Size by Application (2025-2030)
7.3.3 Europe Transdermal and Transmucosal Drug Delivery Market Share by Application (2019-2030)
7.4 Europe Transdermal and Transmucosal Drug Delivery Market Size by Country
7.4.1 Europe Transdermal and Transmucosal Drug Delivery Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Transdermal and Transmucosal Drug Delivery Market Size by Country (2019-2024)
7.4.3 Europe Transdermal and Transmucosal Drug Delivery Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Transdermal and Transmucosal Drug Delivery Market Size (2019-2030)
8.2 China Transdermal and Transmucosal Drug Delivery Market Size by Type
8.2.1 China Transdermal and Transmucosal Drug Delivery Market Size by Type (2019-2024)
8.2.2 China Transdermal and Transmucosal Drug Delivery Market Size by Type (2025-2030)
8.2.3 China Transdermal and Transmucosal Drug Delivery Market Share by Type (2019-2030)
8.3 China Transdermal and Transmucosal Drug Delivery Market Size by Application
8.3.1 China Transdermal and Transmucosal Drug Delivery Market Size by Application (2019-2024)
8.3.2 China Transdermal and Transmucosal Drug Delivery Market Size by Application (2025-2030)
8.3.3 China Transdermal and Transmucosal Drug Delivery Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Transdermal and Transmucosal Drug Delivery Market Size (2019-2030)
9.2 Asia Transdermal and Transmucosal Drug Delivery Market Size by Type
9.2.1 Asia Transdermal and Transmucosal Drug Delivery Market Size by Type (2019-2024)
9.2.2 Asia Transdermal and Transmucosal Drug Delivery Market Size by Type (2025-2030)
9.2.3 Asia Transdermal and Transmucosal Drug Delivery Market Share by Type (2019-2030)
9.3 Asia Transdermal and Transmucosal Drug Delivery Market Size by Application
9.3.1 Asia Transdermal and Transmucosal Drug Delivery Market Size by Application (2019-2024)
9.3.2 Asia Transdermal and Transmucosal Drug Delivery Market Size by Application (2025-2030)
9.3.3 Asia Transdermal and Transmucosal Drug Delivery Market Share by Application (2019-2030)
9.4 Asia Transdermal and Transmucosal Drug Delivery Market Size by Region
9.4.1 Asia Transdermal and Transmucosal Drug Delivery Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Transdermal and Transmucosal Drug Delivery Market Size by Region (2019-2024)
9.4.3 Asia Transdermal and Transmucosal Drug Delivery Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Transdermal and Transmucosal Drug Delivery Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Transdermal and Transmucosal Drug Delivery Market Size by Type
10.2.1 Middle East, Africa, and Latin America Transdermal and Transmucosal Drug Delivery Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Transdermal and Transmucosal Drug Delivery Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Transdermal and Transmucosal Drug Delivery Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Transdermal and Transmucosal Drug Delivery Market Size by Application
10.3.1 Middle East, Africa, and Latin America Transdermal and Transmucosal Drug Delivery Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Transdermal and Transmucosal Drug Delivery Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Transdermal and Transmucosal Drug Delivery Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Transdermal and Transmucosal Drug Delivery Market Size by Country
10.4.1 Middle East, Africa, and Latin America Transdermal and Transmucosal Drug Delivery Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Transdermal and Transmucosal Drug Delivery Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Transdermal and Transmucosal Drug Delivery Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 3M
11.1.1 3M Company Details
11.1.2 3M Business Overview
11.1.3 3M Transdermal and Transmucosal Drug Delivery Introduction
11.1.4 3M Revenue in Transdermal and Transmucosal Drug Delivery Business (2019-2024)
11.1.5 3M Recent Developments
11.2 Antares Pharma
11.2.1 Antares Pharma Company Details
11.2.2 Antares Pharma Business Overview
11.2.3 Antares Pharma Transdermal and Transmucosal Drug Delivery Introduction
11.2.4 Antares Pharma Revenue in Transdermal and Transmucosal Drug Delivery Business (2019-2024)
11.2.5 Antares Pharma Recent Developments
11.3 Aveva Drug Delivery Systems
11.3.1 Aveva Drug Delivery Systems Company Details
11.3.2 Aveva Drug Delivery Systems Business Overview
11.3.3 Aveva Drug Delivery Systems Transdermal and Transmucosal Drug Delivery Introduction
11.3.4 Aveva Drug Delivery Systems Revenue in Transdermal and Transmucosal Drug Delivery Business (2019-2024)
11.3.5 Aveva Drug Delivery Systems Recent Developments
11.4 Corium International
11.4.1 Corium International Company Details
11.4.2 Corium International Business Overview
11.4.3 Corium International Transdermal and Transmucosal Drug Delivery Introduction
11.4.4 Corium International Revenue in Transdermal and Transmucosal Drug Delivery Business (2019-2024)
11.4.5 Corium International Recent Developments
11.5 DURECT
11.5.1 DURECT Company Details
11.5.2 DURECT Business Overview
11.5.3 DURECT Transdermal and Transmucosal Drug Delivery Introduction
11.5.4 DURECT Revenue in Transdermal and Transmucosal Drug Delivery Business (2019-2024)
11.5.5 DURECT Recent Developments
11.6 Pantec Biosolutions
11.6.1 Pantec Biosolutions Company Details
11.6.2 Pantec Biosolutions Business Overview
11.6.3 Pantec Biosolutions Transdermal and Transmucosal Drug Delivery Introduction
11.6.4 Pantec Biosolutions Revenue in Transdermal and Transmucosal Drug Delivery Business (2019-2024)
11.6.5 Pantec Biosolutions Recent Developments
11.7 Tapemark
11.7.1 Tapemark Company Details
11.7.2 Tapemark Business Overview
11.7.3 Tapemark Transdermal and Transmucosal Drug Delivery Introduction
11.7.4 Tapemark Revenue in Transdermal and Transmucosal Drug Delivery Business (2019-2024)
11.7.5 Tapemark Recent Developments
11.8 Tesa Labtec
11.8.1 Tesa Labtec Company Details
11.8.2 Tesa Labtec Business Overview
11.8.3 Tesa Labtec Transdermal and Transmucosal Drug Delivery Introduction
11.8.4 Tesa Labtec Revenue in Transdermal and Transmucosal Drug Delivery Business (2019-2024)
11.8.5 Tesa Labtec Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
3M
Antares Pharma
Aveva Drug Delivery Systems
Corium International
DURECT
Pantec Biosolutions
Tapemark
Tesa Labtec
听
听
*If Applicable.
